About Us
Overview
Mission and Vision
Board of Directors
Awards & Recognitions
Business Areas
Overview
India - Branded Generics
Emerging Markets - Branded Generics
USA - Generics
Manufacturing
Overview
Manufacturing Facilities
Quality
Sustainability
R&D
Investors
Financials
Corporate Governance
Investor Information
Media
Press Release
Media Coverage
Media Kit
Career
Life at Ajanta
Work with Us
CSR
Contact Us
Search
Statutory Communications 2022-23 | Ajanta Pharma Investors
Investor
Information
Home
-
Investors
Investor Information
Miscellaneous
2026-27
2025-26
2024-25
2023-24
2022-23
2021-22
2020-21
2019-20
2018-19
2017-18
2016-17
2015-16
CSR annual action plan for 2022-2023
Related Links
Statutory Communications
Unclaimed Dividend
Unclaimed Shares
Investor Contact
Smart ODR & KYC form
FAQs
Buyback
Miscellaneous
